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Abstract 
Objectives 
Among benign tumours of the parotid gland, basal cell adenoma (BCA) is far 
less common than pleomorphic adenoma (PA). Magnetic resonance (MR) features of 
BCA, including diffusion-weighted imaging and dynamic contrast-enhanced study, 
have not been previously described. Assessment of the crucial MR features of BCA 
appears to offer beneficial clues for distinguishing BCA from PA.  
Methods 
We retrospectively reviewed 14 BCAs and 179 PAs in the parotid gland, collected 
between March 2000 and May 2012, from the MR imaging database.. 
Results 
Nearly half of the BCAs had cystic components. The average ratio of the 
maximum diameter of the cysts to the BCAs (cystic ratio) was 0.80 ± 0.11 [standard 
deviation(SD)]. The BCA cystic ratio was significantly higher (p=0.00232) than that 
of PAs. The cystic ratio threshold was 0.65 between cystic BCA and cystic PA. 
Sensitivity and specificity were 76.5% and 100%, respectively. The average of the 
apparent diffusion coefficient (ADC) values of the 12 BCAs (1.24 ± 0.18 [SD] 
x10-3mm2/sec) was significantly lower  than that of the 151 PAs (1.86 ± 0.40 [SD] 
x10-3mm2/sec) (p<0.001) and also that of the cystic PAs (1.83 ± 0.57 [SD] 
x10-3mm2/sec) (p=0.00495). The ADC threshold was 1.31 x10-3mm2/sec between 
BCA and cystic PA, with sensitivity and specificity of 81.2% and 91.7%, 
respectively, and also the same 1.31 x10-3mm2/sec between BCA and PA, with 
sensitivity and specificity of 92.7% and 91.7%, respectively. Time–signal intensity 
curves (TICs) showed various patterns. 
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Conclusions 
Small cystic mass with well-circumscribed borders and slightly lower ADC 
value may suggest BCA, although TICs showed various patterns.  
 
Introduction 
By the previous WHO classification (1991), basal cell adenoma (BCA) was 
recognized as an independent entity among salivary gland tumours. Although the 
incidence of BCA is 1-7.5%, it is the third most common type of benign parotid 
tumour [1, 2]. BCA predominantly affects persons over 50 years of age and is seen 
more often in females. Most BCAs are unilateral and round or oval in shape with 
well-circumscribed borders, and they are usually less than 3.0 cm in diameter in the 
superficial lobe of the parotid gland at the time of excision. A painless, slowly 
enlarging mass is the most common clinical symptom. Some surgeons have mistaken 
these tumours for lymph nodes clinically. The accuracy of the cytological diagnosis 
of BCA is not so good [3]. The majority of BCAs arise in the major glands, with the 
parotid gland being the most frequent site. BCAs are composed of basaloid cells with 
eosinophilic cytoplasm, have indistinct cell borders and round to oval nuclei, and are 
distributed in solid, trabecular, tubular, and membranous patterns [4]. However, the 
tumours may present with more than one of these patterns, although one will usually 
predominate. Membranous BCA has biologic behavior different from that of the 
other variants of BCA in that it has multifocal microadenomas, incomplete or no 
capsules, frequent postoperative recurrences, and malignant transformations [4]. 
 Pleomorphic adenoma (PA) is the most common benign neoplasm of parotid 
gland origin, being the most common neoplasm of the salivary gland even in children 
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and adolescents [5]. Women are more likely to be affected than men. PA is usually 
solitary, round, and well-circumscribed, with a smooth but sometimes lobulated 
surface. Tumours larger than 1-cm diameter often have numerous protuberances, 
giving them a lobulated appearance. PAs are commonly encapsuled in parotid glands. 
PAs are renowned for their cytomorphological and architectural variability. Despite 
their protean histopathology, all tumours share the essential diagnostic features of 
being composed of both epithelial and myxoid tissues [5]. The proportions of these 
components vary widely, although one or the other is often predominant. The variety 
of magnetic resonance (MR) findings of PAs reflects their cytomorphological and 
architectural variability [6]. The diagnostic clue of PA is to find the myxoid 
component, which shows high intensity on short-inversion-time inversion recovery 
(STIR) and T2-weighted images, progressive enhancement on dynamic MR images, 
and high apparent diffusion coefficient (ADC) values on diffusion-weighted (DW) 
images [6]. 
 Warthin’s tumour (WT) is the second most common type of benign parotid 
tumour. Its incidence is markedly higher in elderly males and most tumours develop 
in the inferior pole of the parotid gland [7]. The features of WT are different from 
those of PA [8]. Typical WT shows early enhancement and high washout ratio on 
dynamic enhanced study, and low ADC value on DW images [8]. 
Of course, clinicians want to know first whether a parotid gland tumour is 
malignant or benign. If it is the former, they want to know whether it is low- or 
high-grade malignancy. However, if it is benign, they want to know whether it is PA 
tending to recur, or others. Surgical treatment for PA is a complete, wide surgical 
excision with a good safety margin, and inadequate resection or rupture of the capsule 
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or tumour spillage during excision can lead to local recurrence. WT undergoes local 
excision, as there is no worry about the margin. As for BCA, the prognosis is good 
except for the membranous type. The recurrence rate is so low as to be almost 
non-existent, especially when conservatively but adequately excised. If it is possible to 
show the BCA on MRI to the clinician, it will provide useful information. 
There are few reports regarding MR imaging findings of BCAs, and 
especially any including dynamic enhanced study and ADC values [9-13]. The 
present study aimed to describe the MR features of BCAs and to clarify the 
differences between BCAs and PAs. 
 
Materials and Methods 
Patients 
We retrospectively reviewed 14 BCAs (5 men and 9 women; median 52 
years, range 39-75 years) and 179 PAs (51 men and 128 women; median 48 years, 
range 16-84 years) in the parotid gland, collected between March 2000 and April 
2012 from the MR imaging database of our hospital. 
MR Imaging Techniques 
All MRI examinations were performed using 1.5-T MRI units (GE Medical 
Systems, Milwaukee, WI, USA) with a neurovascular array coil. T1-weighted images 
(400-560/8-14 [repetition time msec./echo time msec.]) of the transverse plane, STIR 
images (3000-4000/30-40, 12 [echo train length], 150 [inversion time msec.]) of the 
same transverse plane as the T1-weighted images, DW images (spin-echo single-shot 
echo-planar sequence with b factors of 0 and 1,000 sec/mm2) of the same transverse 
plane, and T2-weighted SE images (4000/104, 16 [echo train length]) of the coronal 
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plane were obtained at a section thickness of 6 mm, an intersection gap of 1 mm, an 
acquisition matrix of 256 x 256, and a field of view (FOV) of 22 x 22 cm.   
Dynamic contrast-enhanced MR images were obtained by three-dimensional 
fat suppression T1-weighted multiphase spoiled gradient-recalled-echo (SPGR) 
(6.3/1.5 [repetition time msec./echo time msec.]) for 4 min, with each phase lasting 
27 sec followed by a 3-sec interval, an effective section thickness of 4 mm, a FOV of 
22 x 22 cm, and an acquisition matrix of 256 x 256. After the first set was obtained, 
contrast material injection was started immediately. Gadodiamide hydrate was 
administered (0.2 ml/kg body weight) at a rate of 2.0 ml/sec followed by a 20-ml 
saline flush into the antecubital vein. Seven sets of dynamic contrast-enhanced 
images were obtained serially at 3, 33, 63, 93, 123, 153, and 183 sec. Soon after the 
dynamic contrast-enhanced MR imaging, fat suppression T1-weighted images 
(340-400/20 [repetition time msec./echo time msec.]) of the same transverse plane as 
the pre-contrast enhanced T1-weighted images were obtained. Apparent diffusion 
coefficient (ADC) maps were automatically constructed from DW images. 
Image and Pathological Analysis 
All MR images were retrospectively evaluated with respect to size, location, 
marginal morphology (definition and lobulation), and enhancement behavior by 2 
experienced radiologists (H.M and K.M). The signal intensities of the lesions on each 
dynamic image were measured with an electronic cursor to define the region of 
interest (ROI) in each patient. Where markedly heterogeneous enhancement was 
seen, multiple ROIs were obtained. When measuring the signal intensities, obvious 
cystic portions were avoided. Time–signal intensity curves (TICs) of the solid 
components of the lesions on dynamic MRIs were plotted, and washout ratios were 
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also calculated. TICs were divided into 3 types: Type A, curve peaks earlier than 120 
sec (<120 sec) after administration of contrast material with a high washout ratio 
(>30%); Type B, curve peaks earlier than 120 sec (<120 sec) with a low washout 
ratio (<30%); Type C, curve peaks later than 120 sec (>120 sec) [14]. 
 The ADC values of the lesions were measured on each DW image with an 
electronic cursor to define the ROI. When measuring the signal intensities, obvious 
cystic portions were avoided. 
Statistical Analysis 
Mann-Whitney U test was used to compare the size and ADC values of BCAs and 
PAs. The optimal cutoff values for the cystic ratio and ADC value were calculated by 
means of receiver operating characteristic (ROC) analysis for distinguishing between 
BCAs and PAs. All statistical analyses were performed with EZR (Saitama Medical 
Center, Jichi Medical University), which is a graphical user interface for R (The R 
Foundation for Statistical Computing, version 2.13.0) [15]. 
 
Results 
MR Imaging Findings 
Size, Location, and Marginal Morphology 
The average maximal cross-sectional diameter of 14 BCAs was 2.7 ± 0.77 
cm [SD] (1.5 - 4.4 cm). Twelve BCAs (86%) were located in the superficial lobe of 
the parotid gland and the other 2 (14%) in the deep lobe. All BCAs showed 
well-defined margins, and 4 tumours (29%) had lobulated margins. Six of the 14 
BCAs (43%) had cystic components. The average maximal diameter of the cysts was 
2.3 ± 0.96 cm [SD] and the average ratio of the maximum diameter of the cysts to the 
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tumours (cystic ratio) was 0.80 ± 0.11 [SD] (0.65-0.90). 
 The average maximal cross-sectional diameter of 179 PAs was 2.8 ± 1.3 cm 
[SD] (0.7 – 11 cm). One hundred and sixty-two PAs (91%) were located in the 
superficial lobe of the parotid gland and the other 17 (9%) in the deep lobe. 
Seventeen of the 179 PAs (9%) had cystic components. The average maximal 
diameter of the cysts was 1.7 ± 0.80 cm [SD] and the cystic ratio was 0.48 ± 0.21 
[SD] (0.20-0.88).  
There was no significant difference between BCAs and PAs in maximal 
cross-sectional diameter. The cystic ratio of the BCAs was significantly higher than 
that of the PAs (p=0.00232). The cystic ratio threshold derived from the ROC 
curve-based positive test was 0.65 between cystic BCA and cystic PA. Sensitivity 
and specificity were 76.5% and 100%, respectively. 
ADC Values of Tumours 
DW images were obtained from 12 of the 14 BCAs and 151 of the 179 PAs, 
and the ADC values of the tumours were calculated. The average of the ADC values 
of the 12 BCAs (1.24 ± 0.18 [SD], 0.74 to 1.50 x10-3mm2/sec) was significantly 
lower than that of the 151 PAs (1.86 ± 0.40 [SD], 1.09 to 2.86 x10-3mm2/sec) 
(p<0.001) and also that of the cystic PAs (1.83 ± 0.57 [SD], 1.09 to 2.86 
x10-3mm2/sec) (p=0.00495). The ADC thresholds derived from the ROC curve-based 
positive test were 1.31 x10-3mm2/sec between BCA and PA, with sensitivity and 
specificity of 92.7% and 91.7%, respectively. 
Time-versus-contrast Enhancement Ratio and Washout Ratio of Tumours 
Two of the 14 (14%) BCAs had type A curve, 2 (14%) had type B curves, 5 
(36%) had type B and C curves, and 5 (36%) had type C curves. Three of the 17 
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cystic PAs (18%) had type B curves, 2 (12%) had type B and C curves, and 12 (70%) 
had type C curves. Comparison of the imaging features between BCAs and PAs are 
summarized in Table 1. 
Correlations between Radiological and Pathological Findings  
All BCAs had fibrous capsules at the maximal diameter section. Ten of the 
BCAs were classified as trabecular dominant type, one as tubular dominant type, and 
three as solid dominant type. Twelve BCAs existed in the superficial lobe and 2 in 
the deep lobe. Cystic changes were seen in 6 tumours, 5 of which were in the 
superficial lobe and 1 in the deep lobe. Large fibrous scars were seen in 2 BCAs and 
small fibrous scars in 4. Cystic degeneration was seen in 6 BCAs. All BCAs had 
many vascular channels. Subtypes, ADC values, TICs, and washout ratio of the 
tumours are summarized in Table 2. 
In Case 10 (Fig. 1), the tumour in the superficial lobe of the left parotid 
gland had a solid component showing type B enhancement and a large cyst. The 
cystic ratio was 0.68. The pathological specimen revealed the trabecular type of 
BCA, with anastomosing cords of basaloid cells and intervening stroma. 
In Case 11 (Fig. 2), the tumour in the deep lobe of the right parotid gland 
showed type C enhancement and had an ADC value of 1.31 x10-3mm2/sec. The 
pathological specimen revealed the trabecular type of BCA, with rich intervening 
stroma. 
In comparative images of cystic PA (Fig. 3), the tumour in the deep lobe of 
the right parotid gland showed type C enhancement and had an ADC value of 1.52 
x10-3mm2/sec. The cystic ratio was 0.22. Cystic PA had smaller cystic ratio and 
higher ADC value than BCA. TIC curve of cystic PA was type C as shown 
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in some BCA. 
Discussion 
In this study, the median age of BCA patients was 52 years. All BCAs were 
unilateral and had well-circumscribed borders. A painless, slowly enlarging mass was 
the usual clinical symptom. The average maximal cross-sectional diameter of the 14 
BCAs was 2.7 ± 0.77 cm [SD]. Our data agreed well with those of previous articles. 
Four of the 14 BCAs (29%) had lobulated margins in this study. Generally, a 
lobulated appearance is a particular feature of PA when it is larger than 1 cm.  
According to Shi et al [10], BCA in the superficial region tends to be solid 
and small in size. Cystic BCAs occur mostly in the deeper region. This trend was not 
observed in our study, but 6 of the 14 BCAs (43%) had cystic components. On the 
other hand, only 17 of the 179 PAs (9%) showed cystic degeneration in our study. 
The cystic ratio of the BCAs was significantly higher than that of the PAs 
(p=0.00232), and the cystic ratio threshold was 0.65 between cystic BCA and cystic 
PA. 
Some MR imaging findings of BCAs of the parotid gland have been reported 
[11-13], but those reports have not included DW images, ADC values, and TICs with 
washout ratio. MR imaging findings of basal cell adenomas are relatively low signal 
intensities on T1-weighted images and hypointense to slightly hyperintense on 
T2-weighted images, showing rapid and prolonged enhancement on dynamic study. 
BCA sometimes has cystic or hemorrhagic components. In fact, it is difficult to make 
a differential diagnosis between BCA and PA from only the slight difference in the 
signal intensities on T1-weighted and T2-weighted images. In our study, in 9 of the 
14 BCAs (64%), 2 had type A, and 7 had type B curves on dynamic enhanced study, 
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with rapidly enhanced components. Ten of the 14 BCAs (71%) had gradual upward 
enhanced components. According to past articles of parotid tumours, the types of 
TICs at gadolinium-enhanced dynamic MR imaging correlate well with 
histopathologic findings. Rapid enhancement and high washout ratio (type A) for 
Warthin’s tumours, low washout ratio (type B) for malignant tumours, and gradual 
upward enhancement (type C) for pleomorphic adenomas were observed in most 
instances. In our study, 7 of the 14 BCAs (50%) had malignant type of TIC (type B) 
at gadolinium-enhanced dynamic MR imaging. Tumour cells, vascular channels, 
ductal lumen, stroma, and fibrosis were mixed at various proportions in the BCAs. 
These various proportions resulted in a variety of TICs on dynamic MR images: type 
A, cellular component-dominant area showing early enhancement and high washout 
ratio; type B, cellular components with moderate stroma and fibrosis showing early 
enhancement with poor washout; type C, abundant stroma or fibrotic tissue with few 
cellular components showing gradual upward enhancement. Our study also reports 
the ADC values on diffusion-weighted images in patients with BCA. The average of 
the ADC values of the BCAs (1.24 ± 0.18 [SD] x10-3mm2/sec) was significantly 
lower than that of the PAs (1.86 ± 0.40 [SD] x10-3mm2/sec). The ADC threshold was 
1.31 x10-3mm2/sec between BA and PA. There is no report of specific ADC value of 
BCA, although Yerli showed that ADC value of adenomas including 6 PA and 2 BCA 
was 1.75 ± 0.40 x10-3mm2/sec[16]. Our result of ADC value on PA and BCA seems 
to be compatible with the previous report. A previous article reported an ADC 
threshold of 1.22, or 1.40 x10-3mm2/sec between malignancy and PA. The ADC 
value of BCA in our study was between 0.74 and 1.50 x10-3mm2/sec. According to 
the threshold level of 1.40 x10-3mm2/sec [17], all BCAs except for Case 12 in our 
 12 
study might be classified as malignant tumours. All BCAs had well-defined margins 
suggesting benign tumours morphologically, which indicates a discrepancy with the 
results of TIC and ADC analysis. Because BCA is a relatively rare benign epithelial 
tumour, past MR study of salivary gland tumours did not include BCAs [17]. The 
BCAs in our study had fibrous capsules, with many of them having fibrous scars and 
cystic degeneration. All BCAs also had many vascular channels. Clear margins as 
benign and TICs as malignant or PA may reflect these pathological features. 
Although the ADC values and TICs may classify BCA as malignant according to past 
study [17], the morphological features of a clear margin and relatively small size, 
less than 3.0 cm in diameter, suggest BCA as being benign. Large cystic ratio and 
slightly lower ADC value are clues for differentiating BCA and PA.  
Our study has some limitations. First, this study had a relatively small 
number of BCA. We had no membranous-type BCA and most of our cases consisted 
of trabecular type. Thus, our study population might not make a satisfactory 
assessment of the correlation between pathological types and MR results. Further 
studies in more patients are needed. Second, manual ROI setting to measure TIC and 
ADC value is a subjective method. However, the ROI method is the most common 
method in previous papers [6, 8, 14, 17]. We set ROIs as carefully as passible to 
maintain consistency among TIC, ADC value and pathological features. 
In conclusion, BCA predominantly affected older persons (> 50 years) and 
occurred more often in females. A painless, slowly enlarging mass was the main 
clinical symptom. All BCAs (except membranous type) were unilateral small masses, 
usually less than 3.0 cm in diameter, with well-circumscribed borders. BCA often 
had a cystic component, and the ratio of the maximum diameter of the cysts to the 
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tumours in BCA was significantly higher than that in PA. The cystic ratio threshold 
was 0.65 between cystic BCA and cystic PA. The ADC values of BCA (1.24 ± 0.17 
[SD], 0.74 to 1.50 x10-3mm2/sec) were significantly lower than those of PA. Cystic 
small mass with well-circumscribed borders and slightly lower ADC value may 
suggest BCA regardless of the TIC pattern.  
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Table 1 
Comparison of imaging features between BCAs and PAs 
MR fingings BCAs PAs p value 
Diameter of the tumours (cm) 2.7±0.77(1.5-4.4) 2.8±1.3(0.7-11) 0.88993 
Tumour site* 86 % 91 % 
Cystic components 43 %(6/14) 9 %(17/179) 
Diameter of the cysts (cm) 2.3±0.96 1.7±0.8 
Cystic ratio 0.80±0.11 0.48±0.21 
TICs type A   14 % type B   18 % 
 type B   14 % type C   70 % 
 type C   36 % type B+C 12 % 
 type B+C 36 % 
ADC values(x10-3 mm2/sec) 1.24±0.18(0.74-1.50) 1.86±0.40(1.09-2.86) <0.001 
  1.83±0.57(1.09-2.86):cystic PAs 0.00495 
*Ratios for the superficial lobe tumour 
 
Table 2 
Clinical and imaging features of BCA 
Case Age Sex Tumour size Cyst size Cystic ratio ADC value TICs  Tumour site 
   (cm) (cm)  (x10-3mm2/sec) type 
#1 53 F 2.9 2.6 0.90 - B, C   S 
#2 60 F 2.1 1.7 0.81 - C   S 
#3 67 M 2.8 2.5 0.89 1.25 B   S 
#4 40 F 2.1 - - 1.22 C   S 
#5 42 M 3.0 - - 1.29 B, C   S 
#6 61 F 1.7 1.2 0.65 1.23 A   S 
#7 51 F 3.7 - - 1.30 B, C   S 
#8 41 M 2.8 - - 1.23 B, C   S 
#9 39 M 4.4 3.9 0.89 1.25 C   D 
#10 56 F 2.6 1.8 0.68 1.28 B   S 
#11 49 F 2.3 - - 1.31 C   D 
#12 75 F 4.4 - - 1.50 B, C   S 
#13 43 F 2.6 - - 0.74 C   S 
#14 68 M 2.3 - - 1.29 A   S 
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F female, M male, S superficial lobe tumour, D deep lobe tumour 
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Figures  
Figure 1 
 
BCA in the left parotid gland of a 56-year-old female. A, STIR image (3000/40 
[TR/TE], axial plane) shows a superficial lobe tumour with moderately high intensity 
in the peripheral region and markedly high intensity in the central area (*). The 
markedly high intensity area is a cystic lesion. B, T1-weighted image (560/8, axial 
plane) shows a hypo-intensity tumour (arrows). C, T2-weighted image (4000/104, 
coronal plane) shows a low intensity capsule around the tumour (arrows). The ratio 
of the maximum diameter of the cyst to this tumour (cystic ratio) is 0.68. D, On axial 
dynamic enhanced study, TIC of the solid component of this tumour (solid line) 
shows type B early enhancement with poor washout ratio (4%). The cystic region 
(dashed line) shows no enhancement. The ADC value of the solid component is 
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1.28x 10-3 mm2/sec. E, Loupe image on axial section of the specimen with 
hematoxylin-eosin (HE) staining shows solid and large cystic components (**). The 
large cyst had lost its contents. F, Solid component has anastomosing cords of 
basaloid cells and a small amount of intervening stroma (x100 HE staining). 
 
Figure 2 
 
BCA in the right parotid gland of a 49-year-old female. A, On STIR image (3000/40 
[TR/TE], axial plane), the deep lobe tumour shows heterogeneous high intensities 
(arrows). B, On T1-weighted image (560/8, axial plane), the tumour shows 
iso-intensity for muscle (arrows). The ADC value of the tumour component is 1.28x 
10-3 mm2/sec. C and D, Fat suppression contrast enhanced T1-weighted image 
(540/8.2, axial plane) and TIC on enhanced dynamic study, with the tumour showing 
heterogeneous enhancement (arrows) with TIC curve peaks later than 120 sec (type 
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C). E and F, Loupe and light microscopy (original magnification, x100) images 
show the solid component with anastomosing cords of basaloid cells and rich 
intervening stroma (***).  
 
Figure 3 
 
Cystic PA in the right parotid gland of a 37-year-old male. A, On STIR image 
(3000/40 [TR/TE], axial plane), the deep lobe tumour shows heterogeneous 
moderately high intensities with cystic component in the peripheral region (arrows). 
B, T2-weighted image (4000/104, coronal plane) shows a low intensity capsule 
(arrowhead). The cystic component is located in the peripheral region (arrow). The 
cystic ratio is 0.22. C and D, Fat suppression contrast enhanced T1-weighted image 
(540/8.2, axial plane) and TIC on enhanced dynamic study, with the tumour showing 
heterogeneous enhancement and type C TIC curve. The cystic component has no 
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enhancement (arrows). The ADC value of the solid component was 1.52 x10-3 
mm2/sec. 
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